Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...

Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people...

Neonatology

Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...

Neonatology

Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the...

Rare Diseases

Rare Diseases The term rare applies to those diseases affecting a limited number of people with...

Rare Diseases

Rare Diseases The term rare applies to those diseases affecting a limited number of people with...

13
01/20

NEWS

Chiesi Group and Apotex Inc. finalize agreement for acquisition of Ferriprox®...

Chiesi Group expands distribution network via acquisition for worldwide product rights. Chiesi...

PRESS RELEASE

Chiesi Group Announces Establishment of New Global Rare...

Specialized division focused on research and product development for rare and ultra-rare diseases highlights Chiesi’s...

Global Corporate Development

© 2020 CHIESI Farmaceutici S.p.A.

VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

CHIESI ON THE WEB

follow us on: